ECM
IART icon

Evergreen Capital Management’s Integra LifeSciences IART Stock Holding History

Evergreen Capital Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-24,262
Closed -$229K – 1601
2026
Q1 		$229K Buy
+24,262
New +$266K 0.01% 1308

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Evergreen Capital Management's IART Position: Q2 2026 in Review

Evergreen Capital Management sold out of Integra LifeSciences (IART) in Q2 2026, closing a stake of 24,262 shares — an estimated $229K sold.

Evergreen Capital Management first reported a position in IART in Q1 2026 and held it in 1 quarter. The position peaked at $229K in Q1 2026. 213 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Evergreen Capital Management reported no remaining Integra LifeSciences position as of Q2 2026 after selling out during the quarter.
  • Evergreen Capital Management sold 24,262 Integra LifeSciences shares in Q2 2026, an estimated $229K.
  • Evergreen Capital Management first reported a position in Integra LifeSciences in Q1 2026 and held it in 1 quarter.
  • Evergreen Capital Management's Integra LifeSciences position peaked at $229K in Q1 2026.
  • 213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Evergreen Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.